Extrapyramidal Disorders
📧 Sign up to get email alerts when something new happens for Extrapyramidal Disorders.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-07-03FDA Approved: BENZTROPINE MESYLATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for benztropine mesylate, submitted by Fresenius Kabi USA, LLC.
-
FDA approval · 2010-11-17FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Original Application (Bionpharma Inc.)
FDA approved the generic Trihexyphenidyl hydrochloride under an Original Application by Bionpharma Inc.
-
FDA approval · 2009-07-28FDA Approved: BENZTROPINE MESYLATE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for benztropine mesylate (generic) by Fresenius Kabi USA, LLC, expanding access to treatment for Parki…